Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07639450 |
| Title | N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors (Solid Tumors) |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Hefei Xinzhu Biological Technology Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GenesisCare Research | Saint Leonards | New South Wales | 2065 | Australia | Details | |
| San Clinical Trials Unit | Wahroonga | New South Wales | 2076 | Australia | Details | |
| Corner Edith & Platt Streets, , NSW 2298 Australia | Waratah | New South Wales | 2298 | Australia | Details | |
| Hunan Cancer Hospital | Changsha | Hunan | 410013 | China | Details | |
| Shanghai East Hospital | Shanghai | Shanghai Municipality | 200000 | China | Details | |
| Henan Cancer Hospital | Zhengzhou | Zhengzhou | 450000 | China | Details |